Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease
Clinical trial NCT03949894 · COMPLETED
Trial details
- NCT number
- NCT03949894
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2022-05-25
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.